Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01231919Phase 1Completed
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic LeukemiaRecurrent Grade 1 Follicular Lymphoma+38 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score24%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Refractory Chronic Lymphocytic LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia+36 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaAccelerated Phase Chronic Myelogenous Leukemia+25 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Shaji Kumar

Mayo Clinic

Related
10 trials

Shared therapeutic areas:

Refractory Chronic Lymphocytic LeukemiaPost-Transplant Lymphoproliferative DisorderPrimary Central Nervous System Non-Hodgkin Lymphoma+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Guillermo Garcia-Manero

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicBlastic Phase Chronic Myelogenous LeukemiaRelapsing Chronic Myelogenous Leukemia+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Nitin Jain

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Recurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Alex F Herrera

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Ajay Gopal

Fred Hutch/University of Washington Cancer Consortium

Related
8 trials

Shared therapeutic areas:

Recurrent Mantle Cell LymphomaPost-Transplant Lymphoproliferative Disorder

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Elias Jabbour

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Acute Undifferentiated LeukemiaChronic Phase Chronic Myelogenous Leukemia

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01231919Phase 1PrincipalInvestigator

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
Completed

All 1 trials loaded